March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
Stock Buybacks in Defense: What Drives Them, and How That Can Change?
Commentary
Lack of capital is not a problem hindering investment at the largest defense primes. The issue revolves around the capital allocation decision....
By Mikhail Grinberg, Jerry McGinn & Lloyd Everhart
-
Ukrainian president has stark new warning as war rages on
Video
Ukrainian President Volodymyr Zelensky warns that Ukraine will lose the war with Russia without US assistance. Franz-Stefan Gady of CNAS explains why US military aid is crucia...
By Franz-Stefan Gady
-
Sharper: Maritime Security
Commentary
The importance of securing the maritime domain is rapidly increasing. From the South China Sea to the Red Sea, the U.S. and its allies are experiencing escalating challenges t...
By Anna Pederson & Charles Horn
-
Innovation Adoption for All: Scaling across Department of Defense
Commentary
The Department of Defense does act quickly when properly motivated and catalyzed by effective leadership....
By Robert O. Work, Michael Brown & Ellen Lord
